Online ISSN: 1949-2553
www.oncotarget.com
About Oncotarget
Our mission is to make scientific results rapidly and widely available. We seek to maximize the impact of research via insightful review, to enable exceptional discoveries to be shared quickly, to eliminate the border between specialties, to link different fields of biomedical science, and to foster application of basic and clinical science to fight disease.

LEARN MORE ABOUT ONCOTARGET

Bacterial Therapy Revelations in Prostate Cancer

Oncotarget

November 1, 2021
Researchers reveal their positive findings from a 2020 study on a strain of Salmonella typhimurium used in bacterial cancer therapy for mouse-modeled prostate cancer. continue reading »

New Study: Vaccine Enhances Breast Cancer Treatment

Oncotarget

October 27, 2021
Researchers conducted a study to examine the efficacy of adding the P10s-PADRE vaccine to chemotherapy treatments for patients with HR+/HER2− breast cancer. continue reading »

Table of Contents: Oncotarget’s Volume 12, Issue #22

Oncotarget

October 26, 2021
Read short summaries of the latest oncology-focused research published in this week’s issue of Oncotarget, Volume 12, Issue 22. continue reading »

EMT Resistance in Cancer Cells and Two Potential Causes

Oncotarget

October 21, 2021
Researchers used mathematical modeling to investigate mechanisms that drive the elusive phenomenon of cancer cell resistance to epithelial-mesenchymal transition (EMT). continue reading »

New Study: ATR Inhibition Reverses Chemo-Resistance in Subset of Cells

Oncotarget

October 13, 2021
Ataxia telangiectasia and Rad3 (ATR) inhibition was targeted in an attempt to overcome temozolomide (TMZ) resistance in a subset of MGMT-negative and MMR-proficient cancer cell lines. continue reading »